In this issue:
- ANDURA: updated survival with osimertinib
- KRAS mutation: sotorasib vs docetaxel
- Lorlatinib after alectinib
- SABR ± immunotherapy
- Artificial intelligence for:
– Predicting lung cancer recurrence
– Adding value to lung cancer detection
- Survivorship: what is important
- Global patterns of lung cancer mortality
- Patterns of care for SCLC
Please login below to download this issue (PDF)